Rhone-Poulenc puts HRT (hormone replacement therapy) patch on US sale:
This article was originally published in Clinica
Executive Summary
Rhone-Poulenc Rorer is selling its CombiPatch transdermal hormone replacement therapy patch in the US, following approval in August. The Collegeville, Pennsylvania-based company says that CombiPatch is the first continuous oestrogen and progesterone continuous therapy available in the US.